FUNDING SIGNALS

Real Signals. Real Leads. Real Deals.

The only platform that turns real-time signals into your perfect leads

Know Who, Why, and When to reach out — instantly.

FundzWatch™ AI Scoring

10-25 leads daily

Real-time alerts

★★★★★

4.8/5 on G2• High Performer Fall 2025

Used by teams at LinkedIn, HubSpot & Oracle

🔒 app.fundz.net

TechCorp

📍 San Francisco👥 85

Post-Funding

⭐ Ideal Match

Just raised $40M Series B - high purchase intent window

Iso Ray, Inc. announced it raised $729,000 in an initial filing from an offering of $729,000

Jul 25, 2018•about 7 years ago

Amount Raised

$729,000

Round Type

seed

RichlandHealthcare

Company News

(9 articles)

Tue, 18 Oct 2022 07:00:00 GMT

Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 p.m. EDT - Business Wire

Tue, 12 Dec 2023 08:00:00 GMT

GT Medical Technologies, Inc. Agrees to Acquire Radioactive Seed Assets from Perspective Therapeutics, Inc. - PR Newswire

Wed, 28 Sep 2022 07:00:00 GMT

Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results - Stock Titan

Mon, 06 Feb 2023 08:00:00 GMT

Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted Precision Oncology Medicine - Business Wire

Wed, 15 May 2024 07:00:00 GMT

Perspective Therapeutics sells subsidiary to Arizona company - The Business Journals

Mon, 15 Sep 2025 11:03:35 GMT

Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma - GlobeNewswire

Wed, 14 Aug 2019 07:00:00 GMT

Efficacy of Isoray's Cesium Blu Showcased in Recent Studies - Imaging Technology News

Mon, 15 Apr 2024 07:00:00 GMT

GT Medical Technologies, Inc. Completes Strategic Acquisition of Radioactive Seed Assets from Perspective Therapeutics, Inc. - PR Newswire

Mon, 13 Jan 2025 08:00:00 GMT

Breast Cancer Brachytherapy Market Sees $1.88 Billion Opportunity by 2035: Elekta, Varian Medical Systems, and Isoray Dominate the Competitive Landscape - GlobeNewswire

FundzWatch™ Score

Medium Activity

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech